Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 82
Page 225
... Clinical remission in ulcerative colitis is accompanied by endoscopic healing in up to 70 % of cases . The risk of relapse is lower if clinical improve- ment is associated with endoscopic and histological healing . Endoscopic healing ...
... Clinical remission in ulcerative colitis is accompanied by endoscopic healing in up to 70 % of cases . The risk of relapse is lower if clinical improve- ment is associated with endoscopic and histological healing . Endoscopic healing ...
Page 235
... clinical symptoms occur . Unfortunately , no specific laboratory tests are available to differentiate between Crohn's disease and ulcerative colitis . There have been several attempts to develop useful clinical scoring systems to ...
... clinical symptoms occur . Unfortunately , no specific laboratory tests are available to differentiate between Crohn's disease and ulcerative colitis . There have been several attempts to develop useful clinical scoring systems to ...
Page 239
... clinical benefit resulting from the assessment of serum cytokine levels in comparison with routine clinical lab- oratory parameters of inflammation as discussed above . The value of cytokines in the routine analysis has not yet been ...
... clinical benefit resulting from the assessment of serum cytokine levels in comparison with routine clinical lab- oratory parameters of inflammation as discussed above . The value of cytokines in the routine analysis has not yet been ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis